Skip Navigation
Search Menu

 
Print This Page
Share this page: More
 

Bloomberg~Kimmel Institute for Cancer Immunotherapy

immunotherapy

Harnessing The Power of The Immune System

Cancer immune therapy is one of the most promising areas of cancer research. It makes cancer cells visible to immune cells and causes the immune system to take action against cancer. Our scientists have been in the forefront of the field, conducting research aimed at figuring out how and why the immune system is diverted from attacking cancer cells. For more than three decades, the Kimmel Cancer Center has played a key role in advancing this science with world-renowned immunology experts like Drew Pardoll, Elizabeth Jaffee, Jonathan Powell, and Suzanne Topalian leading the way. Much like the cancer cell, the immune cell and system have proven to be extraordinarily complex, but our experts have demonstrated that they are up to the challenge.

Our expertise in cancer immunology, genetics, and epigenetics, which thrives in an environment of collaboration, has been key to making progress. It has resulted in new findings that have been transferred to patient care with unprecedented speed. Checkpoint blockades—which block signals cancer cells use to neutralize the immune system—have resulted in remarkable and lasting responses in patients with melanoma and lung cancer, and are now being explored in other cancers. 

“Immune therapy is a game changer. We need more research to take us the rest of the distance, but we don’t think there is a single cancer that the patient’s own immune system ultimately can’t beat.”
–Cancer Immunologist Drew Pardoll, M.D., Ph.D.

What is Immunotherapy: Bloomberg~Kimmel Institute for Cancer Immunotherapy

Drew Pardoll, M.D., Ph.D., Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Co-Director of the Cancer Immunology Program at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center explains what is immunotherapy and how it is changing cure rates for cancer patients.

Cancer Immunotherapy - Patient Perspective

Metastatic colon cancer patient, Stefanie tells her success story with immunotherapy and how it saved her life.

Learn more about the Bloomberg~Kimmel Institute for Cancer Immunotherapy

 

 A Special Program of Research: Promise and Progress at the Bloomberg~Kimmel Institute for Cancer Immunotherapy

 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

NCI CCC